Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
: https://europepmc.org/article/MED/35021063 , https://europepmc.org/article/MED/31819264 , https://europepmc.org/article/MED/31561945 , https://europepmc.org/article/MED/39747019 Profile Master’s in bio
-
established collaborations and access to centralized facilities with expertise in genomics, functional genomics and cell biology, proteomics, cutting-edge microscopy, structural biology, technology development
-
to integrate immunology, stem cell technology, and Parkinson’s biology. Supervise junior colleagues, contribute to grant writing, and disseminate findings through high-impact publications. Requirements PhD in
-
from non-neuroscience fields but with a keen interest in understanding the brain (e.g., physics, artificial intelligence, engineering, humanities, and medical training) are also strongly encouraged
-
ample opportunities for direct validation in biologically relevant settings. This interdisciplinary atmosphere has been a main catalyst for many past successes: https://europepmc.org/article/MED/35021063
-
environment. Adhere to all laboratory safety guidelines. Requirements A professional Bachelor’s or Master’s degree in Biomedical Laboratory technology, Genetics, Molecular biology, Biochemistry
-
: https://europepmc.org/article/MED/35021063 , https://europepmc.org/article/MED/31819264 , https://europepmc.org/article/MED/31561945 , https://europepmc.org/article/MED/39747019 , https://europepmc.org
-
://europepmc.org/article/MED/31561945 , https://europepmc.org/article/MED/39747019 Profile Master’s in bio-engineering, medicine, molecular biology, immunology, or related FELASA certification Experience in either
-
in vitro and in living cells The applicant will benefit from access to centralized facilities (in particular Nanobody technology, proteomics, cutting-edge microscopy and structural biology). Please
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based